Sarah Lehman

Sarah Lehman, Ph.D., is a principal scientist at Edgewise Therapeutics with a background in muscle physiology and expertise in sarcomere biophysics. Sarah has experience in both in vitro and in vivo studies and is focused on testing and implementing therapeutic targets for muscle diseases. Prior to their current role, Sarah worked as a postdoctoral researcher and fellow at the University of Colorado, where Sarah furthered their research in this field. Sarah also served as a graduate research assistant at the University of Arizona, investigating biophysical derangements in hypertrophic cardiomyopathy. Sarah holds a Ph.D. in Physiology from the University of Arizona and a Bachelor of Science in Chemical Biology from Stevens Institute of Technology.